Vaping a gateway to smoking for non-smokers, research shows
While vaping provides a pathway to help smokers wanting to quit, for non-smokers it may be the first step on a pathway to taking up smoking, a new… read more.
While vaping provides a pathway to help smokers wanting to quit, for non-smokers it may be the first step on a pathway to taking up smoking, a new… read more.
A study involving more than 745,000 adolescents from 41 countries across Europe and North America identified an increase in the amount of teenagers who underestimate their body weight…. read more.
People caring for family members at home (family caregivers) face more substantial psychological and physical challenges than noncaregivers. Therefore, healthcare professionals must pay attention to the stress of… read more.
The results of a clinical trial have shown that a drug commonly used for patients with bleeding disorders has the potential to be used to lessen the side… read more.
For many people, the day doesn’t start until their coffee mug is empty. Coffee is often thought to make you feel more alert, so people drink it to… read more.
Opioid pain-relieving medicines are not more effective than a placebo in relieving acute back and neck pain and may even cause harm, according to a world-first trial led… read more.
Increasing access to prescription opioid painkillers may reduce opioid overdose deaths in the United States, according to a Rutgers study. “When access to prescription opioids is heavily restricted,… read more.
Trevena, Inc. announced new topline Olinvyk data from the ARTEMIS study. The ARTEMIS study was an electronic medical records (EMR) based assessment focused on clinical and health resource… read more.
The true number of autistic people in England may be more than double the number often cited in national health policy documents, suggests a new study by UCL… read more.
Neurologic illnesses, including Alzheimer’s, brain cancer, amyotrophic lateral sclerosis (ALS) and stroke, are among the most dreaded illnesses in medicine and leading causes of disability and death worldwide…. read more.
Researchers report that treatment with bempedoic acid in high-risk primary prevention patients who cannot tolerate recommended doses of statins reduces major adverse cardiovascular events. The findings were published… read more.
AbbVie announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of atogepant for the… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.